• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.解析肠道微生物群与心血管疾病之间的复杂关系。
Circulation. 2024 May 14;149(20):1543-1545. doi: 10.1161/CIRCULATIONAHA.123.067547. Epub 2024 May 13.
2
Gut Microbiota and Cardiovascular Diseases: Unraveling the Role of Dysbiosis and Microbial Metabolites.肠道微生物群与心血管疾病：揭示生态失调和微生物代谢产物的作用
Int J Mol Sci. 2025 Apr 30;26(9):4264. doi: 10.3390/ijms26094264.
3
Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.肠道微生物群及其代谢物对慢性肾脏病心血管并发症的贡献作用。
Semin Nephrol. 2018 Mar;38(2):193-205. doi: 10.1016/j.semnephrol.2018.01.008.
4
[Microbiome, diabetes and heart: a novel link?].[微生物群、糖尿病与心脏：一种新的联系？]
Herz. 2019 May;44(3):223-230. doi: 10.1007/s00059-019-4791-x.
5
The gut microbiota as a novel regulator of cardiovascular function and disease.肠道微生物群作为心血管功能和疾病的新型调节因子。
J Nutr Biochem. 2018 Jun;56:1-15. doi: 10.1016/j.jnutbio.2017.12.010. Epub 2017 Dec 27.
6
[The relationship between gut microbiota and cardiovascular diseases].[肠道微生物群与心血管疾病之间的关系]
G Ital Cardiol (Rome). 2016 Jan;17(1):11-4. doi: 10.1714/2140.23182.
7
Gut Microbiome in Chronic Kidney Disease.慢性肾脏病中的肠道微生物群
Curr Hypertens Rep. 2017 Apr;19(4):29. doi: 10.1007/s11906-017-0727-0.
8
Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.解析微生物组在神经源性高血压中的作用的机制见解：全面综述。
Pathol Res Pract. 2023 Sep;249:154740. doi: 10.1016/j.prp.2023.154740. Epub 2023 Aug 6.
9
Antibiotic-induced gut dysbiosis: unraveling the gut-heart axis and its impact on cardiovascular health.抗生素诱导的肠道菌群失调：揭示肠道-心脏轴及其对心血管健康的影响。
Mol Biol Rep. 2025 Mar 17;52(1):319. doi: 10.1007/s11033-025-10425-2.
10
Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.发育源性心血管疾病：靶向肠道微生物群的预防治疗策略。
Nutrients. 2021 Jul 1;13(7):2290. doi: 10.3390/nu13072290.

引用本文的文献

1
Microbiota and kidney disease: the road ahead.微生物群与肾脏疾病：未来之路
Nat Rev Nephrol. 2025 Oct;21(10):702-716. doi: 10.1038/s41581-025-00988-5. Epub 2025 Jul 28.
2
Gut microbiota dysbiosis exacerbates heart failure by the LPS-TLR4/NF-κB signalling axis: mechanistic insights and therapeutic potential of TLR4 inhibition.肠道微生物群失调通过LPS-TLR4/NF-κB信号轴加重心力衰竭：TLR4抑制的机制见解和治疗潜力
J Transl Med. 2025 Jul 10;23(1):762. doi: 10.1186/s12967-025-06821-8.
3
Complex system modeling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria.复杂系统建模显示，草酸盐稳态由多种草酸盐降解细菌驱动。
Elife. 2025 May 1;14:RP104121. doi: 10.7554/eLife.104121.
4
Gut-X axis.肠-X轴
Imeta. 2025 Feb 26;4(1):e270. doi: 10.1002/imt2.270. eCollection 2025 Feb.
5
Lactobacillus gasseri prevents ibrutinib-associated atrial fibrillation through butyrate.加氏乳杆菌通过丁酸预防依鲁替尼相关的心房颤动。
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf018.
6
The Organ-Joint Axes in Osteoarthritis: Significant Pathogenesis and Therapeutic Targets.骨关节炎中的器官-关节轴：重要的发病机制与治疗靶点
Aging Dis. 2024 Nov 21;16(5):2999-3021. doi: 10.14336/AD.2024.1223.
7
Complex system modelling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria.复杂系统建模显示，草酸盐稳态由多种草酸盐降解细菌驱动。
bioRxiv. 2025 Feb 19:2024.10.28.620613. doi: 10.1101/2024.10.28.620613.

本文引用的文献

1
Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality.微生物产生的咪唑丙酸与心力衰竭和死亡率有关。
JACC Heart Fail. 2023 Jul;11(7):810-821. doi: 10.1016/j.jchf.2023.03.008. Epub 2023 Apr 26.
2
Gut Microbiota-Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms.肠道微生物衍生的三甲胺 N-氧化物通过炎症和凋亡机制导致腹主动脉瘤。
Circulation. 2023 Apr 4;147(14):1079-1096. doi: 10.1161/CIRCULATIONAHA.122.060573. Epub 2023 Apr 3.
3
Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease.两种不同的肠道微生物途径共同导致苯乙酰谷氨酰胺的代谢产物生成，这与心血管疾病有关。
Cell Host Microbe. 2023 Jan 11;31(1):18-32.e9. doi: 10.1016/j.chom.2022.11.015. Epub 2022 Dec 21.
4
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism.丙酸通过免疫依赖调节肠道胆固醇代谢来减轻动脉粥样硬化。
Eur Heart J. 2022 Feb 10;43(6):518-533. doi: 10.1093/eurheartj/ehab644.
5
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential.开发一种靶向肠道微生物的非致死性治疗方法，以抑制血栓形成潜力。
Nat Med. 2018 Sep;24(9):1407-1417. doi: 10.1038/s41591-018-0128-1. Epub 2018 Aug 6.

Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.

作者信息

Tang W H Wilson, Hazen Stanley L

机构信息

Center for Microbiome and Human Health, Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, OH.

出版信息

Circulation. 2024 May 14;149(20):1543-1545. doi: 10.1161/CIRCULATIONAHA.123.067547. Epub 2024 May 13.

DOI:10.1161/CIRCULATIONAHA.123.067547
PMID:38739698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11095831/
Abstract
摘要